These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9527686)

  • 21. Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder.
    Dell'Osso B; Buoli M; Hollander E; Altamura AC
    World J Biol Psychiatry; 2010 Feb; 11(1):59-65. PubMed ID: 20001657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Yale-Brown Obsessive Compulsive Scale: factor analysis, construct validity, and suggestions for refinement.
    Deacon BJ; Abramowitz JS
    J Anxiety Disord; 2005; 19(5):573-85. PubMed ID: 15749574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of moderate-intensity aerobic exercise for obsessive compulsive disorder.
    Brown RA; Abrantes AM; Strong DR; Mancebo MC; Menard J; Rasmussen SA; Greenberg BD
    J Nerv Ment Dis; 2007 Jun; 195(6):514-20. PubMed ID: 17568300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor analysis of the Yale-Brown Obsessive Compulsive Scale in a family study of obsessive-compulsive disorder.
    Cullen B; Brown CH; Riddle MA; Grados M; Bienvenu OJ; Hoehn-Saric R; Shugart YY; Liang KY; Samuels J; Nestadt G
    Depress Anxiety; 2007; 24(2):130-8. PubMed ID: 16892417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of severity and change in obsessive compulsive disorder.
    Goodman WK; Price LH
    Psychiatr Clin North Am; 1992 Dec; 15(4):861-9. PubMed ID: 1461801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
    Poyurovsky M; Faragian S; Shabeta A; Kosov A
    Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
    Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obsessive-compulsive symptoms in patients with panic disorder.
    Torres AR; Dedomenico AM; Crepaldi AL; Miguel EC
    Compr Psychiatry; 2004; 45(3):219-24. PubMed ID: 15124153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
    DeVeaugh-Geiss J; Katz R; Landau P; Goodman W; Rasmussen S
    Psychopharmacol Bull; 1990; 26(1):54-9. PubMed ID: 2196627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical picture of obsessive-compulsive disorder with poor insight: a regression model.
    Bellino S; Patria L; Ziero S; Bogetto F
    Psychiatry Res; 2005 Sep; 136(2-3):223-31. PubMed ID: 16125785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
    Bergeron R; Ravindran AV; Chaput Y; Goldner E; Swinson R; van Ameringen MA; Austin C; Hadrava V
    J Clin Psychopharmacol; 2002 Apr; 22(2):148-54. PubMed ID: 11910259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring obsessive-compulsive symptoms: Padua Inventory-Revised vs. Yale-Brown Obsessive Compulsive Scale.
    Anholt GE; van Oppen P; Emmelkamp PM; Cath DC; Smit JH; van Dyck R; van Balkom AJ
    J Anxiety Disord; 2009 Aug; 23(6):830-5. PubMed ID: 19443176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of aqueous extract of Echium amoenum in treatment of obsessive-compulsive disorder.
    Sayyah M; Boostani H; Pakseresht S; Malaieri A
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1513-6. PubMed ID: 19737592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personality dimensions in obsessive-compulsive disorder: relation to clinical variables.
    Alonso P; Menchón JM; Jiménez S; Segalàs J; Mataix-Cols D; Jaurrieta N; Labad J; Vallejo J; Cardoner N; Pujol J
    Psychiatry Res; 2008 Jan; 157(1-3):159-68. PubMed ID: 17900706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder.
    Fontaine R; Chouinard G
    J Clin Psychopharmacol; 1986 Apr; 6(2):98-101. PubMed ID: 3517083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder.
    Geller DA; Biederman J; Reed ED; Spencer T; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):36-44. PubMed ID: 7860454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obsessive-compulsive disorder and migraine with medication-overuse headache.
    Cupini LM; De Murtas M; Costa C; Mancini M; Eusebi P; Sarchielli P; Calabresi P
    Headache; 2009 Jul; 49(7):1005-13. PubMed ID: 19496831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.